Você procurou por: haemoglobinuria (Inglês - Letão)

paroxysmal nocturnal haemoglobinuria
paroksismāla nakts hemoglubinūrija

paroxysmal nocturnal haemoglobinuria (pnh);
paroksismālo nakts hemoglobinūriju (pnh);

in paroxysmal nocturnal haemoglobinuria (pnh):
paroksismālās nakts hemoglobinūrijas (pnh) ārstēšanai:

soliris (eculizumab) is indicated for the treatment of patients with paroxysmal nocturnal haemoglobinuria (pnh).
soliris (ekulizumabs) ir indicēts paroksismālās nakts hemoglobīnūrijas (pnh) pacientu ārstēšanai.

soliris is used for the treatment of patients with a certain type of disease affecting the blood system called paroxysmal nocturnal haemoglobinuria (pnh).
soliris lieto, lai ārstētu pacientus ar asinsrites sistēmas slimību, ko sauc par paroksismālo nakts hemoglobinūriju (pnh).

soliris is used to treat adults and children patients with a certain type of disease affecting the blood system called paroxysmal nocturnal haemoglobinuria (pnh).
soliris lieto, lai ārstētu pieaugušos un bērnus ar asinsrites sistēmas slimību, ko sauc par paroksismālo nakts hemoglobinūriju (pnh).

a small amount of unstabilised tetrameric haemoglobin (<5 %) may be excreted through the kidneys, resulting in transient haemoglobinuria for < 4 hours.
neliels daudzums nestabila tetramēriska hemoglobīna (< 5 %) var izdalīties caur nierēm, rezultātā uz < 4 stundām izraisot pārejošu hemoglobinūriju.

soliris is used to treat patients with paroxysmal nocturnal haemoglobinuria (pnh), a rare, life- threatening genetic disease that causes the red blood cells to be broken down too quickly.
soliris lieto, lai ārstētu paroksismālās nakts hemoglobinūrijas (pnh) pacientus.